ClinicalTrials.gg
CompletedNCT07872618SBCHUpdated Oct 13, 2026

Effect of Spiritual-Based Clinical Hypnotherapy on Maternal Anxiety and Infant Weight Gain

An interventional study of Spiritual-Based Clinical Hypnotherapy and Guided Spiritual Care in Maternal Anxiety, sponsored by Hasanuddin University. Completed at 1 site in Indonesia. Open to female participants. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Hasanuddin University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 6 months after the study started (first participant enrolled Apr 2025, registered Oct 2026).
Updated Oct 13, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Sex
Female
01

Study summary

This randomized controlled study evaluates whether spiritual-based clinical hypnotherapy can reduce anxiety among breastfeeding mothers and whether changes in maternal anxiety are associated with infant weight gain. The study includes 50 breastfeeding mothers with infants aged 0-6 months who have mild to moderate anxiety. Participants are randomly assigned to either an intervention group receiving spiritual-based clinical hypnotherapy or a control group receiving guided spiritual care without hypnotherapy. The intervention is provided twice weekly for eight weeks, with each session lasting approximately 45-60 minutes. Maternal anxiety is assessed using the Hamilton Anxiety Rating Scale (HARS) before and after the intervention, while infant weight is measured at baseline and after a two-month follow-up period. The study is conducted at three primary healthcare centers in Bone District, South Sulawesi, Indonesia.

Read the detailed description

This randomized controlled study investigates whether spiritual-based clinical hypnotherapy can reduce anxiety in breastfeeding mothers and explores the relationship between maternal anxiety changes and infant weight gain.

Participants and allocation: Fifty breastfeeding mothers with infants aged 0-6 months and mild to moderate anxiety according to the Hamilton Anxiety Rating Scale (HARS) are enrolled after providing informed consent. Participants are allocated by a simple lottery procedure to either the hypnotherapy group (n=25) or the control group (n=25). Blinding of participants is not feasible because of the nature of the intervention. Mothers with severe psychiatric disorders or current psychotropic medication use, and infants with congenital abnormalities or growth disorders, are excluded.

Intervention and comparator: The intervention consists of structured spiritual-based clinical hypnotherapy administered by a certified therapist twice weekly for eight weeks. Each session lasts approximately 45-60 minutes and incorporates relaxation induction, therapeutic suggestions for anxiety management, and guided dhikr. The control group receives guided dhikr without hypnotherapy, facilitated by an experienced religious practitioner.

Outcomes: Maternal anxiety is measured with the 14-item HARS (score range 0-56) at baseline and after the intervention. Infant weight is recorded using calibrated scales, and weight gain is calculated from the difference between baseline and two-month follow-up measurements.

Setting: The study is conducted at Watampone, Biru, and Bajoe Primary Health Centers in Bone District, South Sulawesi, Indonesia.

Analysis: Between-group baseline characteristics are assessed using chi-square or Fisher's exact tests. Repeated-measures ANOVA is used to examine changes in anxiety over time and the time-by-group interaction. Pearson correlation is used to assess the relationship between anxiety reduction and infant weight gain. Exploratory analyses include stratified linear regression and categorization of anxiety reduction. Complete-case analysis is performed, with statistical significance defined as p\<0.05.

Ethics: Ethical approval was granted by the Ethics Committee of the Faculty of Public Health, Universitas Hasanuddin (Approval No. 431/UN4.14.1/TP.01.02/2025; March 4, 2025). Written informed consent is obtained from all participants.

02

Conditions studied

  • Maternal Anxiety

Keywords

  • maternal anxiety
  • Breastfeeding mothers
  • Spiritual-based clinical hypnotherapy
  • Clinical hypnotherapy
  • Spiritual care
  • Dhikr
  • Infant weight gain
  • Hamilton Anxiety Rating Scale
  • Postpartum mental health
03

In context

Lead sponsor

Hasanuddin University is the lead sponsor of 69 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Breastfeeding mothers with infants aged 0-6 months who had mild to moderate anxiety based on the Hamilton Anxiety Rating Scale (HARS) and were willing to provide .

Exclusion criteria

Exclusion Criteria:

  • Mothers with a history of severe psychiatric disorders or current use of psychotropic medications, and mothers whose infants had congenital abnormalities or growth disorders.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (actual)

Study arms

  • Experimental
    Spiritual-Based Clinical Hypnotherapy

    Spiritual-based clinical hypnotherapy delivered by a certified therapist twice weekly for eight weeks. Each session lasts approximately 45-60 minutes and consists of relaxation induction, therapeutic suggestions for anxiety regulation, and guided dhikr.

    Behavioral: Spiritual-Based Clinical Hypnotherapy

  • Active comparator
    Guided Spiritual Care

    Guided dhikr without hypnotherapy, facilitated by an experienced religious practitioner, twice weekly for eight weeks.

    Behavioral: Guided Spiritual Care

Interventions

  • BehavioralSpiritual-Based Clinical Hypnotherapy

    Spiritual-based clinical hypnotherapy delivered by a certified therapist twice weekly for eight weeks. Each session lasts approximately 45-60 minutes and consists of relaxation induction, therapeutic suggestions for anxiety regulation, and guided dhikr.

  • BehavioralGuided Spiritual Care

    Guided dhikr without hypnotherapy, facilitated by an experienced religious practitioner, twice weekly for eight weeks.

06

What researchers measure

Primary outcomes

  1. Maternal Anxiety Score (HARS)

    Maternal anxiety was assessed using the Hamilton Anxiety Rating Scale (HARS), a clinician-administered 14-item instrument with a total score ranging from 0 to 56. Anxiety was assessed at baseline and post-intervention, and the change in HARS score was calculated.

    Time frame: Baseline and post-intervention (8 weeks)

07

Study locations

1 site
  • Watampone Primary Health Center and Biru Primary Health Center in urban areas, and Bajoe Primary Health Center in a coastal area
    Makassar, South Sulawesi 90245, Indonesia
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07872618
Lead sponsor
Hasanuddin University
Responsible party
Musfira (Principal Investigator, Hasanuddin University) — Principal investigator
First posted
Oct 13, 2026
Start date
Apr 1, 2025
Primary completion
May 27, 2026
Completion
Jun 1, 2026
Last update
Oct 13, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion